prednisone has been researched along with plx4032 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chmielowski, B; Clements, A; Kefford, RF; Klein, O; Long, GV; Ribas, A; Walker, G | 1 |
| Adan, A; Fonollosa, A; Mesquida, M | 1 |
| de Margerie-Mellon, C; Goldwirt, L; How-Kit, A; Lebbe, C; Lorillon, G; Meignin, V; Mourah, S; Pages, C; Tazi, A; Tost, J; Vercellino, L | 1 |
| Angioi-Duprez, K; Boiché, M; Conart, JB | 1 |
| Bhangoo, MS; Saven, A | 1 |
5 other study(ies) available for prednisone and plx4032
| Article | Year |
|---|---|
Facial palsy as a side effect of vemurafenib treatment in patients with metastatic melanoma.
Topics: Antineoplastic Agents, Hormonal; Facial Paralysis; Humans; Indoles; Male; Melanoma; Middle Aged; Prednisone; Sulfonamides; Treatment Outcome; Vemurafenib | 2013 |
Uveitic macular oedema after treatment with vemurafenib.
Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Drug Implants; Glucocorticoids; Humans; Indoles; Macular Edema; Male; Melanoma; Middle Aged; Prednisone; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Vemurafenib; Visual Acuity | 2015 |
Dramatic transient improvement of metastatic BRAF(V600E)-mutated Langerhans cell sarcoma under treatment with dabrafenib.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Drug Substitution; Humans; Imidazoles; Indoles; Langerhans Cell Sarcoma; Lymph Nodes; Male; MAP Kinase Kinase Kinases; Middle Aged; Molecular Targeted Therapy; Multimodal Imaging; Mutation, Missense; Neoplasm Proteins; Oximes; Piperidines; Point Mutation; Positron-Emission Tomography; Prednisone; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Recurrence; Sulfonamides; Tomography, X-Ray Computed; Vemurafenib; Vincristine | 2015 |
[Severe panuveitis in a metastatic cutaneous melanoma patient treated with vemurafenib].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Humans; Melanoma; Neoplasm Metastasis; Panuveitis; Prednisone; Severity of Illness Index; Skin Neoplasms; Vemurafenib; Visual Acuity | 2018 |
Secondary malignancies after treatment with single-agent vemurafenib in two patients with refractory hairy cell leukemia.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Female; Humans; Immunohistochemistry; Leukemia, Hairy Cell; Male; Neoplasms, Second Primary; Prednisone; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Rituximab; Treatment Outcome; Vemurafenib; Vincristine | 2019 |